| <P style="PADDING-RIGHT: 14px; PADDING-LEFT: 8px; PADDING-BOTTOM: 18px; MARGIN: 0px; WORD-SPACING: 0px; FONT: 14px/22px Arial, 宋体; TEXT-TRANSFORM: none; COLOR: rgb(51,51,51); TEXT-INDENT: 2em; PADDING-TOP: 6px; WHITE-SPACE: normal; LIST-STYLE-TYPE: none; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); orphans: 2; widows: 2; webkit-text-size-adjust: auto; webkit-text-stroke-width: 0px">联合医疗公司口服体热treprostinil（曲前列环素）新药申请没有获得美国食品药监局（FDA）批准。</P>
<P style="PADDING-RIGHT: 14px; PADDING-LEFT: 8px; PADDING-BOTTOM: 18px; MARGIN: 0px; WORD-SPACING: 0px; FONT: 14px/22px Arial, 宋体; TEXT-TRANSFORM: none; COLOR: rgb(51,51,51); TEXT-INDENT: 2em; PADDING-TOP: 6px; WHITE-SPACE: normal; LIST-STYLE-TYPE: none; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); orphans: 2; widows: 2; webkit-text-size-adjust: auto; webkit-text-stroke-width: 0px">Treprostinil是一种用于治疗肺动脉高血压（PAH）的药，可通过皮下注射、静脉注射和吸入来治疗。</P>
<P style="PADDING-RIGHT: 14px; PADDING-LEFT: 8px; PADDING-BOTTOM: 18px; MARGIN: 0px; WORD-SPACING: 0px; FONT: 14px/22px Arial, 宋体; TEXT-TRANSFORM: none; COLOR: rgb(51,51,51); TEXT-INDENT: 2em; PADDING-TOP: 6px; WHITE-SPACE: normal; LIST-STYLE-TYPE: none; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); orphans: 2; widows: 2; webkit-text-size-adjust: auto; webkit-text-stroke-width: 0px">FDA之所以没有批准Treprostinil的申请是因为质疑其药效。</P>
<P style="PADDING-RIGHT: 14px; PADDING-LEFT: 8px; PADDING-BOTTOM: 18px; MARGIN: 0px; WORD-SPACING: 0px; FONT: 14px/22px Arial, 宋体; TEXT-TRANSFORM: none; COLOR: rgb(51,51,51); TEXT-INDENT: 2em; PADDING-TOP: 6px; WHITE-SPACE: normal; LIST-STYLE-TYPE: none; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); orphans: 2; widows: 2; webkit-text-size-adjust: auto; webkit-text-stroke-width: 0px">FDA审查委员会称：“TreprostinilIII期研究并不能改善患者的情况。”</P>
<P style="PADDING-RIGHT: 14px; PADDING-LEFT: 8px; PADDING-BOTTOM: 18px; MARGIN: 0px; WORD-SPACING: 0px; FONT: 14px/22px Arial, 宋体; TEXT-TRANSFORM: none; COLOR: rgb(51,51,51); TEXT-INDENT: 2em; PADDING-TOP: 6px; WHITE-SPACE: normal; LIST-STYLE-TYPE: none; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); orphans: 2; widows: 2; webkit-text-size-adjust: auto; webkit-text-stroke-width: 0px">FDA建议联合公司应该开展一个固定剂量和剂量增加的临床研究。</P> |
